Given the changes in the hepatic endocannabinoid system associated with LPS/GalN-induced liver injury, and data demonstrating beneficial effects of CB1 antagonism and CB2 receptor agonism in several models of liver disease [20,27], the effects of modulating these receptors on ALI in SD and WKY rats was examined. Here, GAL is linked to liver disorder.